Oral versus intravenous administration of cyclophosphamide: a case report

BACKGROUND: Cyclophosphamide, an alkylating agent, has been used as an immunosuppressant in the treatment of various autoimmune disorders and malignancies. It is highly capable of reducing T and B lymphocytes. CASE PRESENTATION: Regular blood tests are important to detect bone marrow suppression. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kenneth S, Kwok, Chung, Lok, Aishin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615431/
https://www.ncbi.nlm.nih.gov/pubmed/19077308
http://dx.doi.org/10.1186/1757-1626-1-395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615431/
https://www.ncbi.nlm.nih.gov/pubmed/19077308
http://dx.doi.org/10.1186/1757-1626-1-395

Ejemplares similares